MEMED DIAGNOSTICS LTD - MEMED DIAGNOSTICS- THE R&D EFFORT TO DEMONSTRATE CLINICAL UTILITY OF MEMED BV, RAPID HOST-BASED DIAGNOSTIC (HBD) FOR DISTINGUISHING BACTERIAL VS VIRAL INFECTION

On Oct 31, 2025, Department of Health and Human Services obligated $727,799.32 to MEMED DIAGNOSTICS LTD for memed diagnostics- the r&d effort to demonstrate clinical utility of memed bv, rapid host-based diagnostic (hbd) for distinguishing bacterial vs viral infection. The award is classified under NAICS 541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) and issued as a firm fixed price contract. Competition extent: full and open competition with 99 offers received. The procurement used a NO SET ASIDE USED. set-aside. The contract is scheduled through Oct 31, 2026 — approximately 5 months remaining.